North America Spinal Cord Stimulation Devices Market (2019-2025)
The North America Spinal Cord Stimulation Devices Market would witness market growth of 7.54% CAGR during the forecast period (2019-2025). North America dominated the regional market in 2018 and is anticipated to sustain its dominance in the future as well. This trend is associated with increased cases of chronic pain, CRPS, and failed back syndrome. Furthermore, the widespread awareness about spinal cord stimulation therapy, the existence of well-established healthcare settings, and skilled doctors’ presence in these settings are expected to boost the market growth. It is also anticipated that the rapid acceptance of technologically advanced products will stimulate market growth.
Although stimulation of the spinal cord is the most established part of the therapeutic family known as neuromodulation, its applications are still evolving. The International Neuromodulation Society defines neuromodulation as a therapeutic contact with the central, peripheral, or autonomic treatment interaction with the nervous system through targeted electrical stimulation or pharmacological delivery from implanted equipment.
Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.
Scope of the Study
Market Segmentation:
By Product
Although stimulation of the spinal cord is the most established part of the therapeutic family known as neuromodulation, its applications are still evolving. The International Neuromodulation Society defines neuromodulation as a therapeutic contact with the central, peripheral, or autonomic treatment interaction with the nervous system through targeted electrical stimulation or pharmacological delivery from implanted equipment.
Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.
Scope of the Study
Market Segmentation:
By Product
- Rechargeable
- Non-Rechargeable
- Complex Regional Pain Syndrome
- Unsuccessful Disk Surgery
- Failed Back Syndrome
- Degenerative Disk Disease
- Other Applications
- US
- Canada
- Mexico
- Rest of North America
- Boston Scientific Corporation
- Medtronic PLC
- Abbott Laboratories (St. Jude Medical, Inc.)
- Neurosigma, Inc.
- Nevro Corporation
- Synapse BioMedical, Inc.
- Integer Holdings Corporation
- Stimwave Technologies, Inc.
- Nuvectra Corporation
- Saluda Medical Pty Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Spinal Cord Stimulation Devices Market, by Product
1.4.2 North America Spinal Cord Stimulation Devices Market, by Application
1.4.3 North America Spinal Cord Stimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS
3.1 North America Complex Regional Pain Syndrome Market by Country
3.2 North America Unsuccessful Disk Surgery Market by Country
3.3 North America Failed Back Syndrome Market by Country
3.4 North America Degenerative Disk Disease Market by Country
3.5 North America Other Applications Market by Country
CHAPTER 4. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT
4.1 North America Rechargeable Market by Country
4.2 North America Non-Rechargeable Market by Country
CHAPTER 5. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY
5.1 USA Spinal Cord Stimulation Devices Market
5.1.1 USA Spinal Cord Stimulation Devices Market by Applications
5.1.2 USA Spinal Cord Stimulation Devices Market by Product
5.2 Canada Spinal Cord Stimulation Devices Market
5.2.1 Canada Spinal Cord Stimulation Devices Market by Applications
5.2.2 Canada Spinal Cord Stimulation Devices Market by Product
5.3 Mexico Spinal Cord Stimulation Devices Market
5.3.1 Mexico Spinal Cord Stimulation Devices Market by Applications
5.3.2 Mexico Spinal Cord Stimulation Devices Market by Product
5.4 Rest of North America Spinal Cord Stimulation Devices Market
5.4.1 Rest of North America Spinal Cord Stimulation Devices Market by Applications
5.4.2 Rest of North America Spinal Cord Stimulation Devices Market by Product
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.1 Recent strategies and developments:
6.1.1.1 Product launches:
6.1.1.2 Acquisition and mergers:
6.1.1.3 Collaborations, partnerships and agreements:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product launches:
6.2.5.2 Approvals:
6.3 Abbott Laboratories (St. Jude Medical, Inc.)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product launches:
6.3.5.2 Collaborations, partnerships and agreements:
6.3.5.3 Acquisition and mergers:
6.4 Neurosigma, Inc.
6.4.1 Company Overview
6.5 Nevro Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals:
6.6 Synapse BioMedical, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Collaborations, partnerships and agreements:
6.7 Integer Holdings Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Stimwave Technologies, Inc.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 Nuvectra Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals:
6.1 Saluda Medical Pty Ltd.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product launches:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Spinal Cord Stimulation Devices Market, by Product
1.4.2 North America Spinal Cord Stimulation Devices Market, by Application
1.4.3 North America Spinal Cord Stimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS
3.1 North America Complex Regional Pain Syndrome Market by Country
3.2 North America Unsuccessful Disk Surgery Market by Country
3.3 North America Failed Back Syndrome Market by Country
3.4 North America Degenerative Disk Disease Market by Country
3.5 North America Other Applications Market by Country
CHAPTER 4. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT
4.1 North America Rechargeable Market by Country
4.2 North America Non-Rechargeable Market by Country
CHAPTER 5. NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY
5.1 USA Spinal Cord Stimulation Devices Market
5.1.1 USA Spinal Cord Stimulation Devices Market by Applications
5.1.2 USA Spinal Cord Stimulation Devices Market by Product
5.2 Canada Spinal Cord Stimulation Devices Market
5.2.1 Canada Spinal Cord Stimulation Devices Market by Applications
5.2.2 Canada Spinal Cord Stimulation Devices Market by Product
5.3 Mexico Spinal Cord Stimulation Devices Market
5.3.1 Mexico Spinal Cord Stimulation Devices Market by Applications
5.3.2 Mexico Spinal Cord Stimulation Devices Market by Product
5.4 Rest of North America Spinal Cord Stimulation Devices Market
5.4.1 Rest of North America Spinal Cord Stimulation Devices Market by Applications
5.4.2 Rest of North America Spinal Cord Stimulation Devices Market by Product
CHAPTER 6. COMPANY PROFILES
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.1 Recent strategies and developments:
6.1.1.1 Product launches:
6.1.1.2 Acquisition and mergers:
6.1.1.3 Collaborations, partnerships and agreements:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product launches:
6.2.5.2 Approvals:
6.3 Abbott Laboratories (St. Jude Medical, Inc.)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product launches:
6.3.5.2 Collaborations, partnerships and agreements:
6.3.5.3 Acquisition and mergers:
6.4 Neurosigma, Inc.
6.4.1 Company Overview
6.5 Nevro Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Approvals:
6.6 Synapse BioMedical, Inc.
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Collaborations, partnerships and agreements:
6.7 Integer Holdings Corporation
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Stimwave Technologies, Inc.
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 Nuvectra Corporation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.9.5 Recent strategies and developments:
6.9.5.1 Approvals:
6.1 Saluda Medical Pty Ltd.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product launches:
LIST OF TABLES
TABLE 1 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA FAILED BACK SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA FAILED BACK SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA NON-RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA NON-RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 USA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 24 USA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 25 USA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 26 USA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 27 USA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 28 USA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 29 CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 30 CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 31 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 32 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 33 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 34 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 35 MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 36 MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 37 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 38 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 39 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 42 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 43 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 44 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 45 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 48 KEY INFORMATION – MEDTRONIC PLC
TABLE 49 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 50 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 51 KEY INFORMATION – NEVRO CORPORATION
TABLE 52 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 53 KEY INFORMATION –INTEGER HOLDINGS CORPORATION
TABLE 54 KEY INFORMATION – STIMWAVE TECHNOLOGIES, INC.
TABLE 55 KEY INFORMATION – NUVECTRA CORPORATION
TABLE 56 KEY INFORMATION – SALUDA MEDICAL PTY LTD.
TABLE 1 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA COMPLEX REGIONAL PAIN SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA UNSUCCESSFUL DISK SURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA FAILED BACK SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA FAILED BACK SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA DEGENERATIVE DISK DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA NON-RECHARGEABLE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA NON-RECHARGEABLE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 USA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 24 USA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 25 USA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 26 USA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 27 USA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 28 USA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 29 CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 30 CANADA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 31 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 32 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 33 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 34 CANADA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 35 MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 36 MEXICO SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 37 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 38 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 39 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 MEXICO SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 42 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 43 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2015 - 2018, USD MILLION
TABLE 44 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY APPLICATIONS, 2019 - 2025, USD MILLION
TABLE 45 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 REST OF NORTH AMERICA SPINAL CORD STIMULATION DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 48 KEY INFORMATION – MEDTRONIC PLC
TABLE 49 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 50 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 51 KEY INFORMATION – NEVRO CORPORATION
TABLE 52 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 53 KEY INFORMATION –INTEGER HOLDINGS CORPORATION
TABLE 54 KEY INFORMATION – STIMWAVE TECHNOLOGIES, INC.
TABLE 55 KEY INFORMATION – NUVECTRA CORPORATION
TABLE 56 KEY INFORMATION – SALUDA MEDICAL PTY LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
